CASTIGLIONE, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 99
EU - Europa 74
AS - Asia 57
SA - Sud America 8
AF - Africa 6
Totale 244
Nazione #
US - Stati Uniti d'America 97
IT - Italia 55
SG - Singapore 27
CN - Cina 16
IE - Irlanda 10
BR - Brasile 7
IN - India 7
CI - Costa d'Avorio 4
RU - Federazione Russa 4
VN - Vietnam 3
KR - Corea 2
SN - Senegal 2
AT - Austria 1
BD - Bangladesh 1
CA - Canada 1
DE - Germania 1
FI - Finlandia 1
FR - Francia 1
HN - Honduras 1
SA - Arabia Saudita 1
UA - Ucraina 1
VE - Venezuela 1
Totale 244
Città #
Santa Clara 31
Catania 25
Singapore 22
Chandler 15
Dublin 10
Chicago 9
Abidjan 4
Beijing 4
Civitanova Marche 4
Boardman 3
Cambridge 3
Lawrence 3
Mascalucia 3
Messina 3
Andover 2
Ashburn 2
Augusta 2
Chennai 2
Dakar 2
Hanoi 2
Hefei 2
Kochi 2
Lago 2
Mumbai 2
Seoul 2
Verona 2
Agrigento 1
Arraial do Cabo 1
Atlanta 1
Belo Horizonte 1
Brasília 1
Clarksburg 1
Columbus 1
Coro 1
Des Moines 1
Dhaka 1
Dianivka 1
Dong Ket 1
El Progreso 1
Hebei 1
Jacksonville 1
Jeddah 1
Jiaxing 1
Jundiaí 1
Lake Worth 1
Lappeenranta 1
Mateus Leme 1
Milan 1
Munich 1
Nanjing 1
New Delhi 1
Palermo 1
Priolo Gargallo 1
San Francisco 1
San Giovanni la Punta 1
São João del Rei 1
São Paulo 1
The Dalles 1
Tianjin 1
Toronto 1
Totale 197
Nome #
Cerebellar degeneration-related protein 1 expression in fibroblasts of patients affected by Down syndrome. 81
Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome 72
CCR3 gene overexpression in patients with Down syndrome 55
Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment 41
Totale 249
Categoria #
all - tutte 1.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 1 0 0 2 0 0 0 3 3 1 4
2021/202222 1 4 0 0 2 0 2 3 6 0 0 4
2022/202355 3 3 2 2 8 7 0 8 17 1 1 3
2023/202420 0 4 1 0 2 3 0 3 0 1 5 1
2024/2025109 3 16 4 13 27 13 0 1 3 8 11 10
2025/202619 14 5 0 0 0 0 0 0 0 0 0 0
Totale 249